UPFRONT CYTOREDUCTIVE NEPHRECTOMY IN CHROMOPHOBE RENAL CELL CARCINOMA WITH GASTRIC METASTASIS: CASE REPORT
DOI:
https://doi.org/10.56238/arev8n1-123Keywords:
Renal Cell Carcinoma, Chromophobe Renal Cell Carcinoma, Cytoreductive NephrectomyAbstract
Introduction: Cytoreductive nephrectomy in metastatic renal cell carcinoma (RCC) may be indicated in selected patients, especially those with low prognostic risk, aiming at symptom control, reduction of tumor burden, and better integration with systemic therapy. Case report: A 75-year-old male patient presented with severe left flank pain for approximately 1 month, complaining of abdominal "bloating," without fever, vomiting, or significant weight loss. Abdominal computed tomography (CT) with contrast revealed a large hypervascular solid mass in the left kidney, in addition to a large lesion in the body and fundus of the stomach. The patient underwent a left total nephrectomy associated with partial gastrectomy with gastroplasty. The histopathological examination of the nephrectomy revealed chromophobe renal cell carcinoma, pT3a N0 M1. Conclusion: This case illustrates the rarity of gastric metastasis from chromophobe RCC and demonstrates the importance of CT scans in detecting atypical metastatic sites, prognostic evaluation (low risk according to the IMDC), and cytoreductive nephrectomy associated with metastasis resection in a selected patient.
Downloads
References
[1] RAITER JUNIOR, C. Papel da nefrectomia citorredutora na era da imunoterapia combinada para carcinoma de células renais metastático. Brazilian Journal of Implantology and Health Sciences, v. 7, n. 11, p. 415-423, 2025. DOI: 10.36557/2674-8169.2025v7n11p415-423. DOI: https://doi.org/10.36557/2674-8169.2025v7n11p415-423
[2] BAKOUNY, Z.; EL ZARIF, T.; DUDANI, S.; WELLS, J.; GAN, C. L.; DONSKOV, F. et al. Upfront cytoreductive nephrectomy for metastatic renal cell carcinoma treated with immune checkpoint inhibitors or targeted therapy: an observational study from the International Metastatic Renal Cell Carcinoma Database Consortium. European Urology, v. 83, p. 145-151, 2023. DOI: 10.1016/j.eururo.2022.10.004. DOI: https://doi.org/10.1016/j.eururo.2022.10.004
[3] BHINDI, B.; ABEL, E. J.; ALBIGES, L.; BENSALAH, K.; BOORJIAN, S. A.; DANESHMAND, S. et al. Systematic Review of the Role of Cytoreductive Nephrectomy in the Targeted Therapy Era and Beyond: An Individualized Approach to Metastatic Renal Cell Carcinoma. European Urology, v. 75, p. 111-128, 2019. DOI: 10.1016/j.eururo.2018.09.016. DOI: https://doi.org/10.1016/j.eururo.2018.09.016
[4] EUROPEAN ASSOCIATION OF UROLOGY (EAU). EAU Guidelines on Renal Cell Carcinoma. 2025. Disponível em: https://uroweb.org/guidelines/renal-cell-carcinoma/chapter/disease-management. Acesso em: 08/01/2026.
